You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Obtenez les dernières mises à jour ou faites une autoévaluation.

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

Lignes directrices et conseils
À propos des lignes directrices

Continuous versus Intermittent Chemotherapy Strategies in Inoperable, Advanced Colorectal Cancer

Version: 2 ID: 2-6 sep 2022
Type of Content: Guidelines & Advice, Clinical
Document Status: Current
Authors:
S. Berry, R. Cosby, T. Asmis, K. Chan, M.K. Krzyzanowska, N. Hammad, Gastrointestinal Disease Site Group

Patient Population

Adult patients (≥18 years old) with inoperable, advanced (Stage IV) colorectal cancer.

Intended Guideline Users

Clinicians and healthcare providers involved in the management of patients with advanced colorectal cancer.

Research Question(s)

What is the impact of intermittent strategies of administering systemic therapy on length and quality of survival in patients with untreated, unresectable metastatic colorectal cancer?

pdf download Summary (PDF) (228.83 Ko)
pdf download Full Report (PDF) (951.67 Ko)